NCT07244978 2025-12-02
Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Not yet recruiting
Second Affiliated Hospital, School of Medicine, Zhejiang University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences